已收录 272895 条政策
 政策提纲
  • 暂无提纲
Myofascial Structural Integration Therapy on Gross Motor Function and Gait of Young Children with Spastic Cerebral Palsy: A Randomized Controlled Trial
[摘要] Though the cause of motor abnormalities in cerebral palsy is injury to the brain, structural changes in muscle and fascia may add to stiffness and reduced function. This study examined whether myofascial structural integration therapy, a complementary treatment that manipulates muscle and fascia, would improve gross motor function and gait in children <4 years with cerebral palsy. Participants (N = 29) were enrolled in a randomized controlled trial ({"type":"clinical-trial","attrs":{"text":"NCT01815814","term_id":"NCT01815814"}}NCT01815814, https://goo.gl/TGxvwd) or Open Label Extension. The main outcome was the Gross Motor Function Measure-66 assessed at 3-month intervals. Gait (n = 8) was assessed using the GAITRite® electronic walkway. Parents completed a survey at study conclusion. Comparing Treatment (n = 15) and Waitlist-Control groups (n = 9), we found a significant main effect of time but no effect of group or time × group interaction. The pooled sample (n = 27) showed a main effect of time, but no significantly greater change after treatment than between other assessments. Foot length on the affected side increased significantly after treatment, likely indicating improvement in the children’s ability to approach a heel strike. Parent surveys indicated satisfaction and improvements in the children’s quality of movement. MSI did not increase the rate of motor skill development, but was associated with improvement in gait quality.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 儿科学
[关键词] cerebral palsy;spasticity;children;myofascial structural integration;Rolfing®motor function;gait [时效性] 
   浏览次数:21      统一登录查看全文      激活码登录查看全文